This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| SARS | 190929 |
| CoV-2 | 107772 |
| COVID-19 | 69264 |
| CoV | 36803 |
| ACE2 | 24952 |
| RNA | 23441 |
| China | 20553 |
| PCR | 14761 |
| MERS | 14187 |
| Coronavirus | 13935 |
| S | 13581 |
| Fig | 13471 |
| Wuhan | 11267 |
| RT | 9991 |
| Health | 8740 |
| • | 8326 |
| T | 8202 |
| M | 7656 |
| C | 7407 |
| Table | 7389 |
| RBD | 7307 |
| Disease | 6424 |
| IFN | 5273 |
| CT | 5117 |
| March | 4760 |
| East | 4759 |
| N | 4731 |
| S1 | 4693 |
| II | 4647 |
| IL-6 | 4537 |
| Middle | 4485 |
| IgG | 4449 |
| sha | 4382 |
| TMPRSS2 | 4223 |
| World | 3870 |
| IgM | 3849 |
| J | 3774 |
| HIV | 3771 |
| ARDS | 3744 |
| Hong | 3731 |
| el | 3719 |
| DOI | 3650 |
| Kong | 3611 |
| Syndrome | 3549 |
| ICU | 3547 |
| United | 3525 |
| April | 3508 |
| Figure | 3460 |
| A | 3449 |
| Organization | 3371 |
| Respiratory | 3355 |
| CoVs | 3250 |
| S2 | 3241 |
| Novel | 3189 |
| ELISA | 3159 |
| mg | 3157 |
| States | 3059 |
| Italy | 2940 |
| B | 2923 |
| USA | 2901 |
| Vero | 2892 |
| Hospital | 2852 |
| HCoV | 2793 |
| Human | 2771 |
| CDC | 2743 |
| Clinical | 2728 |
| National | 2663 |
| Control | 2653 |
| May | 2649 |
| CC | 2621 |
| remdesivir | 2606 |
| University | 2578 |
| New | 2577 |
| CD8 | 2538 |
| CoV-1 | 2514 |
| Ebola | 2502 |
| CD4 | 2496 |
| der | 2454 |
| medRxiv | 2450 |
| los | 2440 |
| sera | 2421 |
| US | 2335 |
| February | 2301 |
| Covid-19 | 2272 |
| January | 2225 |
| PPE | 2174 |
| L | 2170 |
| December | 2146 |
| Prevention | 2134 |
| HCQ | 2121 |
| TNF | 2098 |
| Virus | 2089 |
| Singapore | 2070 |
| BY | 2069 |
| OC43 | 2000 |
| NC | 1946 |
| HLA | 1912 |
| Spike | 1903 |
| Research | 1902 |
| D | 1902 |
| WHO | 1899 |
| FDA | 1883 |
| Supplementary | 1865 |
| RdRp | 1864 |
| E | 1844 |
| CI | 1839 |
| June | 1839 |
| Li | 1838 |
| ND | 1836 |
| CoV2 | 1824 |
| Protein | 1818 |
| Center | 1815 |
| Wang | 1799 |
| G | 1792 |
| HIV-1 | 1774 |
| UK | 1771 |
| E6 | 1743 |
| un | 1736 |
| H1N1 | 1679 |
| Remdesivir | 1676 |
| α | 1672 |
| Treatment | 1668 |
| Germany | 1667 |
| PBS | 1666 |
| M. | 1653 |
| Analysis | 1647 |
| Influenza | 1643 |
| COVID | 1629 |
| CoV. | 1616 |
| Europe | 1611 |
| Viral | 1576 |
| Society | 1571 |
| Medical | 1555 |
| pH | 1545 |
| NL63 | 1544 |
| MD | 1544 |
| Data | 1531 |
| IgA | 1530 |
| Mpro | 1526 |
| Infection | 1514 |
| meta | 1513 |
| del | 1513 |
| ritonavir | 1500 |
| Hubei | 1494 |
| International | 1484 |
| Care | 1482 |
| PDB | 1480 |
| Study | 1471 |
| Review | 1471 |
| Association | 1465 |
| Angiotensin | 1459 |
| Structure | 1457 |
| COV-2 | 1447 |
| DNA | 1434 |
| Detection | 1425 |
| July | 1421 |
| ACE-2 | 1407 |
| Korea | 1406 |
| qPCR | 1401 |
| South | 1401 |
| Institute | 1396 |
| N95 | 1394 |
| I | 1382 |
| S. | 1381 |
| Patients | 1375 |
| Taiwan | 1349 |
| F | 1348 |
| para | 1348 |
| Chen | 1346 |
| K | 1342 |
| Hydroxychloroquine | 1341 |
| 3CL | 1340 |
| CNS | 1336 |
| Coronaviruses | 1329 |
| Molecular | 1325 |
| Zhang | 1321 |
| Group | 1319 |
| York | 1314 |
| Pneumonia | 1312 |
| Transmission | 1311 |
| India | 1311 |
| C. | 1308 |
| von | 1306 |
| con | 1295 |
| NK | 1293 |
| Infectious | 1291 |
| Cov-2 | 1291 |
| las | 1290 |
| Ang | 1289 |
| Africa | 1282 |
| Diseases | 1279 |
| hydroxychloroquine | 1276 |
| nan | 1263 |
| E. | 1257 |
| Chinese | 1249 |
| NP | 1240 |
| CSF | 1239 |
| Drug | 1235 |
| MS | 1204 |
| Medicine | 1196 |
| kcal | 1185 |
| J. | 1178 |
| Committee | 1171 |
| ID | 1170 |
| Public | 1156 |
| Science | 1147 |
| HKU1 | 1132 |
| France | 1132 |
| Development | 1125 |
| L. | 1124 |
| Canada | 1106 |
| Cell | 1102 |
| Spain | 1091 |
| Department | 1087 |
| Asia | 1086 |
| Liu | 1082 |
| Province | 1079 |
| Japan | 1076 |
| mRNA | 1074 |
| Pandemic | 1069 |
| LAMP | 1062 |
| Evaluation | 1058 |
| azithromycin | 1055 |
| Toronto | 1052 |
| European | 1049 |
| CQ | 1038 |
| pro | 1033 |
| HCV | 1029 |
| America | 1025 |
| September | 1022 |
| HCoV-229E | 1017 |
| IBD | 1013 |
| Chloroquine | 1011 |
| RSV | 1000 |
| lymphopenia | 999 |
| ACE | 991 |
| R | 990 |
| IC | 977 |
| Beijing | 972 |
| American | 970 |
| Use | 969 |
| Guangdong | 969 |
| una | 969 |
| August | 968 |
| pacientes | 967 |
| MHV | 959 |
| H5N1 | 959 |
| en | 951 |
| Centers | 951 |
| System | 941 |
| B. | 941 |
| lopinavir | 934 |
| Antibody | 926 |
| City | 924 |
| Yang | 918 |
| RAS | 918 |
| Dr. | 918 |
| R. | 917 |
| Report | 915 |
| CRP | 908 |
| III | 907 |
| Global | 905 |
| AIDS | 904 |
| ER | 900 |
| Fisher | 895 |
| EM | 895 |
| Saudi | 890 |
| EC | 890 |
| La | 889 |
| Rapid | 884 |
| Emergency | 880 |
| Lancet | 875 |
| K. | 868 |
| Receptor | 865 |
| IL-10 | 862 |
| S3 | 858 |
| Arabia | 858 |
| CA | 857 |
| Wu | 856 |
| Laboratory | 843 |
| Coronaviridae | 828 |
| PLpro | 827 |
| MHC | 826 |
| mit | 824 |
| nucleocapsid | 819 |
| West | 819 |
| IQR | 817 |
| Brazil | 816 |
| mL | 813 |
| U | 798 |
| Roche | 798 |
| AKI | 797 |
| GISAID | 792 |
| tocilizumab | 790 |
| und | 789 |
| ORF | 789 |
| Med | 783 |
| U.S. | 776 |
| por | 773 |
| Zhou | 773 |
| ± | 769 |
| β | 764 |
| Characteristics | 761 |
| Zika | 756 |
| England | 750 |
| Scientific | 749 |
| Journal | 748 |
| BCG | 747 |
| γ | 745 |
| preprint | 744 |
| vivo | 743 |
| Fc | 739 |
| Case | 739 |
| H | 737 |
| Epidemiology | 726 |
| Identification | 725 |
| Healthcare | 725 |
| IV | 724 |
| Risk | 723 |
| Republic | 721 |
| D. | 720 |
| Lopinavir | 718 |
| COPD | 717 |
| van | 712 |
| Ct | 709 |
| Patient | 704 |
| Administration | 704 |
| GI | 703 |
| Kawasaki | 698 |
| HCWs | 698 |
| Management | 696 |
| des | 695 |
| < | 695 |
| como | 693 |
| Huang | 692 |
| Anti | 692 |
| protein | 687 |
| State | 687 |
| RMSD | 686 |
| es | 685 |
| 3a | 685 |
| Ministry | 677 |
| Lung | 675 |
| hepatitis | 668 |
| October | 668 |
| ED | 668 |
| North | 665 |
| Inc. | 663 |
| Immune | 662 |
| P. | 660 |
| November | 660 |
| Discovery | 659 |
| eine | 657 |
| DPP4 | 656 |
| IL-1 | 655 |
| 8) | 654 |
| bei | 653 |
| Commission | 649 |
| Australia | 649 |
| NF | 647 |
| doc_id | 636 |
| Gene | 635 |
| A. | 625 |
| Response | 621 |
| κB | 619 |
| DC | 616 |
| kg | 614 |
| inflammasome | 613 |
| General | 613 |
| Abbott | 613 |
| zu | 612 |
| monocyte | 612 |
| MIS | 611 |
| College | 611 |
| miRNA | 609 |
| VSV | 609 |
| Food | 609 |
| Creative | 608 |
| IVIG | 604 |
| Sigma | 604 |
| Cancer | 603 |
| COVID‐19 | 602 |
| Golgi | 601 |
| MRI | 600 |
| Commons | 600 |
| People | 599 |
| Foundation | 595 |
| Safety | 594 |
| NCBI | 591 |
| NTD | 590 |
| Network | 589 |
| HA | 589 |
| Bat | 588 |
| Vaccine | 588 |
| ORF1ab | 584 |
| Thermo | 583 |
| MM | 581 |
| Trial | 580 |
| H. | 579 |
| Guillain | 578 |
| Centre | 570 |
| du | 569 |
| TGF | 569 |
| TM | 567 |
| Impact | 564 |
| IRF3 | 563 |
| Xu | 562 |
| SARS‐CoV‐2 | 562 |
| Children | 561 |
| Diagnosis | 560 |
| Team | 559 |
| siRNA | 556 |
| Se | 551 |
| GenBank | 549 |
| Invitrogen | 546 |
| miRNAs | 545 |
| Infections | 544 |
| BALB | 539 |
| Dis | 538 |
| den | 536 |
| Severe | 535 |
| OD | 533 |
| CRISPR | 533 |
| G. | 531 |
| Technology | 531 |
| LPV | 527 |
| mAbs | 526 |
| PEDV | 523 |
| qRT | 519 |
| einer | 517 |
| S4 | 516 |
| Inhibitors | 514 |
| IL-8 | 513 |
| El | 513 |
| Kingdom | 511 |
| First | 511 |
| Lu | 510 |
| Aerosol | 509 |
| PubMed | 509 |
| Sciences | 509 |
| Tocilizumab | 509 |
| HCoVs | 508 |
| Effect | 508 |
| werden | 506 |
| CoV-2-specific | 506 |
| Antiviral | 505 |
| covid-19 | 503 |
| SDS | 501 |
| CpG | 500 |
| Clin | 500 |
| Cryo | 497 |
| ADE | 493 |
| EMC | 490 |
| F. | 489 |
| COVID19 | 487 |
| Shanghai | 486 |
| Yu | 485 |
| Zhao | 484 |
| TCR | 484 |
| San | 484 |
| IL-2 | 484 |
| TCID | 482 |
| T. | 482 |
| PD | 480 |
| N. | 480 |
| JAK | 480 |
| endosomal | 475 |
| MAPK | 475 |
| Genome | 474 |
| Outcomes | 474 |
| Lee | 473 |
| Nature | 470 |
| Emerging | 470 |
| Chan | 470 |
| LDH | 469 |
| −1 | 468 |
| Guidelines | 468 |
| Assessment | 468 |
| CFR | 466 |
| Protease | 465 |
| Inhibition | 464 |
| interleukin-6 | 463 |
| ••• | 462 |
| ® | 462 |
| Acute | 461 |
| Ritonavir | 459 |
| Efficacy | 458 |
| SD | 457 |
| CPE | 457 |
| Washington | 456 |
| disease | 455 |
| Nile | 455 |
| le | 454 |
| Tris | 453 |
| IBV | 452 |
| DMEM | 452 |
| COVID-2019 | 452 |
| HR1 | 451 |
| 3C | 451 |
| Viruses | 448 |
| Bio | 448 |
| CVD | 446 |
| Qiagen | 446 |
| Iran | 446 |
| IL-1β | 445 |
| Associated | 444 |
| 3D | 443 |
| ROS | 441 |
| Netherlands | 441 |
| Y | 439 |
| Host | 439 |
| SP | 438 |
| Vietnam | 437 |
| Diagnostics | 437 |
| ml | 436 |
| De | 434 |
| Appendix | 434 |
| HCW | 434 |
| ORF8 | 434 |
| Favipiravir | 433 |
| bronchoalveolar | 432 |
| Kim | 432 |
| NLRP3 | 431 |
| auf | 428 |
| ALI | 428 |
| Meta | 426 |
| S5 | 425 |
| Assay | 424 |
| Methods | 423 |
| Hepatitis | 423 |
| Betacoronavirus | 422 |
| CRS | 422 |
| NIH | 422 |
| favipiravir | 422 |
| su | 421 |
| Mechanisms | 421 |
| Antibodies | 421 |
| Animal | 421 |
| anti | 420 |
| ORF6 | 420 |
| Pathogenesis | 419 |
| Bank | 417 |
| GM | 415 |
| NIV | 414 |
| H7N9 | 414 |
| High | 413 |
| Outbreak | 413 |
| W. | 412 |
| Model | 412 |
| Nipah | 410 |
| Lin | 410 |
| Chest | 410 |
| CTL | 408 |
| Studies | 407 |
| Interferon | 405 |
| X | 403 |
| Testing | 403 |
| HBV | 403 |
| Patienten | 402 |
| Binding | 402 |
| Information | 400 |
| Illumina | 400 |
| Central | 397 |
| KD | 396 |
| NPS | 395 |
| FBS | 394 |
| Corona | 394 |
| ARB | 391 |
| TB | 389 |
| N1 | 389 |
| MOI | 389 |
| Guangzhou | 389 |
| TGEV | 388 |
| Government | 388 |
| doi | 387 |
| Article | 387 |
| HEK293 | 385 |
| Inhibitor | 385 |
| ¼ | 384 |
| | | 383 |
| Cross | 383 |
| BD | 383 |
| AI | 383 |
| − | 383 |
| Michael | 382 |
| Intensive | 382 |
| RaTG13 | 381 |
| Cheng | 381 |
| Function | 380 |
| David | 380 |
| Dynamics | 380 |
| MSC | 380 |
| Systematic | 380 |
| Therapy | 380 |
| Structural | 377 |
| Hospitalized | 376 |
| EUA | 376 |
| Arbidol | 376 |
| Wei | 375 |
| Ethics | 375 |
| CMV | 375 |
| WT | 374 |
| auch | 373 |
| Tang | 373 |
| Potential | 372 |
| GBS | 369 |
| Systems | 369 |
| les | 369 |
| Biological | 368 |
| Phase | 368 |
| DIC | 368 |
| Pediatric | 367 |
| das | 366 |
| V | 365 |
| RBM | 365 |
| sars | 364 |
| Enzyme | 364 |
| Convalescent | 364 |
| Natural | 362 |
| Interaction | 362 |
| GFP | 362 |
| Comparative | 361 |
| ILI | 361 |
| Los | 361 |
| Type | 361 |
| Region | 360 |
| Heart | 359 |
| Extended | 359 |
| Barré | 359 |
| SPSS | 358 |
| PTSD | 358 |
| Activation | 358 |
| RAAS | 357 |
| east | 356 |
| Zhejiang | 356 |
| Sars | 356 |
| bp | 353 |
| sich | 352 |
| Unit | 352 |
| Surface | 352 |
| Shenzhen | 352 |
| Protection | 352 |
| HR2 | 352 |
| multicentre | 351 |
| kb | 350 |
| Lombardy | 350 |
| PE | 349 |
| PAGE | 349 |
| MAVS | 349 |
| ECMO | 349 |
| ATP | 349 |
| infección | 348 |
| Crystal | 347 |
| Shi | 346 |
| IAV | 346 |
| Diagnostic | 345 |
| CD147 | 344 |
| BSA | 344 |
| novo | 343 |
| Cells | 342 |
| se | 341 |
| Thailand | 341 |
| hsa | 340 |
| Early | 340 |
| Council | 339 |
| Based | 339 |
| Entry | 339 |
| casos | 339 |
| lo | 338 |
| chloroquine | 338 |
| Springer | 338 |
| Guidance | 337 |
| Genomic | 337 |
| Effectiveness | 337 |
| Plasma | 336 |
| London | 336 |
| coronaviruses | 335 |
| Zhu | 335 |
| Investigation | 333 |
| IU | 333 |
| Board | 333 |
| MA | 332 |
| Pulmonary | 331 |
| Yan | 331 |
| Sun | 330 |
| ORF1a | 330 |
| VTE | 329 |
| Project | 328 |
| P | 328 |
| Replication | 327 |
| R0 | 327 |
| FP | 327 |
| Supplemental | 326 |
| Prism | 326 |
| μM | 325 |
| mcr-9 | 324 |
| California | 323 |
| Switzerland | 323 |
| Cardiovascular | 323 |
| nicht | 322 |
| HRP | 322 |
| GraphPad | 322 |
| •••• | 322 |
| Xiao | 321 |
| Mann | 321 |
| Ag | 321 |
| Ab | 321 |
| P1 | 320 |
| IFN- | 320 |
| uso | 319 |
| Test | 319 |
| STAT3 | 318 |
| Attribution | 317 |
| Life | 317 |
| Design | 316 |
| Whitney | 315 |
| Panel | 315 |
| Jan | 315 |
| Guan | 315 |
| Technologies | 314 |
| Taxonomy | 314 |
| CTD | 314 |
| nucleoprotein | 313 |
| Tan | 312 |
| Isolation | 312 |
| AutoDock | 312 |
| Activity | 311 |
| I. | 311 |
| Time | 311 |
| ageusia | 310 |
| Virology | 310 |
| NHS | 310 |
| oder | 309 |
| VTM | 309 |
| Summary | 309 |
| N2 | 309 |
| DMSO | 309 |
| Lassa | 308 |
| enfermedad | 307 |
| LPS | 307 |
| Hu | 307 |
| Open | 306 |
| Stem | 305 |
| Prediction | 304 |
| ist | 303 |
| nan | 303 |
| Academy | 303 |
| ADP | 303 |
| þ | 302 |
| Applied | 302 |
| Waals | 301 |
| Le | 301 |
| Community | 301 |
| RDV | 300 |
| 3A | 300 |
| Features | 299 |
| His41 | 298 |
| Chang | 298 |
| Distress | 298 |
| Kumar | 298 |
| parainfluenza | 298 |
| dass | 297 |
| anakinra | 297 |
| Institutional | 297 |
| IL-4 | 297 |
| IFA | 296 |
| MCP-1 | 296 |
| Y. | 296 |
| au | 296 |
| V. | 295 |
| más | 294 |
| aa | 294 |
| IP-10 | 294 |
| Abstract | 294 |
| Agency | 293 |
| TLR4 | 293 |
| i | 293 |
| Sci | 293 |
| author(s | 292 |
| P2 | 292 |
| John | 292 |
| Critical | 292 |
| Adults | 292 |
| pp1a | 291 |
| enzyme-2 | 291 |
| Staphylococcus | 291 |
| Pearson | 291 |
| LMWH | 291 |
| Fusion | 291 |
| Imaging | 290 |
| Biotechnology | 290 |
| zur | 290 |
| Vina | 290 |
| Yi | 290 |
| Expression | 289 |
| BMI | 289 |
| S6 | 288 |
| Escherichia | 288 |
| Q | 287 |
| Polymerase | 286 |
| HCl | 286 |
| mol | 285 |
| Sweden | 285 |
| CD3 | 285 |
| Co | 284 |
| GE | 284 |
| Seroprevalence | 284 |
| ou | 284 |
| tratamiento | 284 |
| Wong | 283 |
| Surveillance | 283 |
| ExoN | 283 |
| TLR | 282 |
| HS | 282 |
| Biotech | 282 |
| _ | 281 |
| Northern | 281 |
| Calu-3 | 281 |
| Biosystems | 280 |
| ORF3a | 280 |
| School | 280 |
| association | 280 |
| coronavirus | 280 |
| interactome | 280 |
| CP | 279 |
| Broad | 279 |
| Ace2 | 279 |
| sobre | 278 |
| SAR | 278 |
| Feb | 278 |
| Factors | 278 |
| estudio | 277 |
| COV | 277 |
| AUC | 277 |
| 2D | 277 |
| Zheng | 276 |
| middle | 276 |
| Smith | 275 |
| RH | 275 |
| Na | 275 |
| IC50 | 275 |
| Social | 274 |
| Pangolin | 274 |
| Kit | 274 |
| NH | 273 |
| Maria | 272 |
| Cardiac | 272 |
| 3B | 272 |
| NMR | 270 |
| ABO | 270 |
| AST | 270 |
| Thomas | 270 |
| Nucleocapsid | 270 |
| Promega | 270 |
| seq | 269 |
| mTOR | 269 |
| TCM | 269 |
| Origin | 269 |
| Belgium | 269 |
| A2 | 269 |
| Reverse | 268 |
| PPI | 268 |
| Princess | 267 |
| Oxford | 267 |
| Microbiology | 267 |
| DAD | 267 |
| Long | 266 |
| Union | 266 |
| Accepted | 265 |
| ser | 264 |
| Program | 264 |
| Epstein | 264 |
| Epidemiological | 264 |
| EC50 | 264 |
| Coronavirus-2 | 264 |
| nsp10 | 263 |
| Green | 263 |
| Director | 263 |
| ALT | 263 |
| PK | 262 |
| Inflammatory | 262 |
| mid | 262 |
| ng | 262 |
| Front | 261 |
| Diamond | 261 |
| Epidemic | 261 |
| Co. | 261 |
| Institutes | 261 |
| Les | 261 |
| Th17 | 261 |
| ••••• | 261 |
| CXCL10 | 260 |
| CR | 260 |
| Alzheimer | 260 |
| disease-2019 | 259 |
| Blood | 259 |
| SA | 258 |
| M2 | 258 |
| Mechanism | 258 |
| SUD | 258 |
| SARS- | 258 |
| riesgo | 258 |
| × | 257 |
| pp1ab | 257 |
| Single | 257 |
| NT | 257 |
| EBOV | 257 |
| Cochrane | 257 |
| subgenomic | 256 |
| Application | 256 |
| IL-18 | 255 |
| Barr | 255 |
| CD | 255 |
| rRT | 255 |
| LC | 255 |
| pseudovirus | 255 |
| NGS | 255 |
| sind | 254 |
| puede | 254 |
| pseudotyped | 254 |
| Inactive | 254 |
| 254 | |
| Expert | 254 |
| C3 | 254 |
| Guo | 253 |
| Gao | 252 |
| DCs | 252 |
| GBSA | 252 |
| Ltd. | 252 |
| SIGN | 252 |
| nelfinavir | 251 |
| interferon | 251 |
| han | 251 |
| VLP | 250 |
| Neutrophil | 250 |
| Immunology | 250 |
| simplex | 249 |
| Ivermectin | 249 |
| Ill | 249 |
| Han | 249 |
| CO | 249 |
| Brain | 248 |
| Al | 248 |
| Recommendations | 248 |
| IL-17 | 248 |
| entre | 247 |
| ORF1b | 247 |
| Ig | 247 |
| EDTA | 247 |
| Int | 246 |
| Emerg | 246 |
| cas | 244 |
| Leu | 244 |
| DTT | 244 |
| Laboratories | 243 |
| Office | 243 |
| Software | 243 |
| ivermectin | 243 |
| paciente | 243 |
| μg | 242 |
| siRNAs | 242 |
| min | 242 |
| Xpert | 242 |
| W | 242 |
| Environmental | 242 |
| AT1R | 242 |
| M1 | 241 |
| DENV | 241 |
| IHR | 241 |
| SNP | 241 |
| ORFs | 241 |
| Synthesis | 241 |
| recomienda | 241 |
| GO | 240 |
| Diego | 240 |
| kDa | 239 |
| Jin | 239 |
| Interim | 239 |
| EGFR | 239 |
| CD26 | 239 |
| BAL | 239 |
| Biosciences | 238 |
| Toll | 238 |
| durch | 238 |
| ein | 238 |
| Ni | 237 |
| Cellular | 237 |
| CCL2 | 237 |
| A59 | 237 |
| mm | 237 |
| pandemia | 236 |
| cobas | 236 |
| Dr | 236 |
| Pan | 235 |
| Song | 234 |
| RMSF | 234 |
| Nidovirales | 233 |
| LF | 233 |
| replicase | 233 |
| wird | 232 |
| helicase | 232 |
| MAS | 232 |
| DR | 232 |
| Azithromycin | 232 |
| Nsp9 | 231 |
| Domain | 231 |
| County | 231 |
| st | 230 |
| aus | 230 |
| Force | 229 |
| CXR | 229 |
| Cao | 229 |
| Stability | 229 |
| Z | 229 |
| als | 229 |
| SL | 228 |
| ML | 228 |
| Hoffmann | 228 |
| HR | 228 |
| Dong | 228 |
| ATCC | 228 |
| camostat | 227 |
| Standard | 227 |
| NY | 227 |
| CLIA | 227 |
| GS-5734 | 226 |
| Access | 226 |
| Chi | 226 |
| antiphospholipid | 226 |
| Ma | 226 |
| β1 | 225 |
| ont | 225 |
| Working | 225 |
| TLR7 | 225 |
| Rhinolophus | 225 |
| Load | 225 |
| Huanan | 225 |
| Aldrich | 225 |
| Liver | 224 |
| ACEI | 224 |
| Findings | 224 |
| Peptide | 224 |
| RNP | 224 |
| Rad | 224 |
| da | 224 |
| Turkey | 223 |
| RA | 223 |
| Paris | 223 |
| Flu | 223 |
| Dengue | 223 |
| Air | 223 |
| Services | 222 |
| Glycoprotein | 222 |
| ST | 222 |
| Ontario | 222 |
| WBC | 222 |
| mesylate | 222 |
| PCA | 222 |
| mM | 222 |
| Nsp1 | 221 |
| Note | 221 |
| 2C | 221 |
| Protocol | 221 |
| Peiris | 219 |
| ADAM17 | 219 |
| Area | 219 |
| Declaration | 219 |
| BBB | 219 |
| SPR | 219 |
| ThermoFisher | 219 |
| WNV | 219 |
| estudios | 219 |
| kappaB | 219 |
| PBSA | 219 |
| Malaysia | 218 |
| Interleukin-6 | 218 |
| Immunity | 218 |
| Contact | 218 |
| hpi | 217 |
| Park | 217 |
| PRISMA | 217 |
| Non | 217 |
| Geneva | 217 |
| Hopkins | 216 |
| Rep | 216 |
| IL | 216 |
| EHV | 216 |
| TLR3 | 216 |
| Van | 216 |
| UCSF | 216 |
| dans | 215 |
| Statistical | 215 |
| TRS | 215 |
| series | 214 |
| Virol | 214 |
| Mycobacterium | 214 |
| Mouse | 214 |
| Yin | 214 |
| MP | 213 |
| 1C | 213 |
| Comparison | 213 |
| Cys | 213 |
| Database | 213 |
| OR | 213 |
| RNase | 213 |
| mRNAs | 213 |
| ≤ | 213 |
| IL-12 | 213 |
| Survey | 212 |
| Jiang | 212 |
| Italian | 212 |
| AP | 212 |
| Multisystem | 211 |
| AU | 211 |
| Yuan | 210 |
| Material | 210 |
| Paul | 210 |
| betacoronaviruses | 210 |
| diagnóstico | 210 |
| sACE2 | 210 |
| Universal | 209 |
| SI | 209 |
| RCT | 209 |
| HMGB1 | 209 |
| Gibco | 209 |
| Chronic | 209 |
| Approach | 209 |
| Americans | 209 |
| AR | 209 |
| Chemical | 208 |
| Cytokine | 208 |
| Israel | 208 |
| Ribavirin | 208 |
| Vitro | 207 |
| Spearman | 207 |
| Pathology | 207 |
| PT | 207 |
| Organisation | 207 |
| Membrane | 207 |
| Marburg | 207 |
| License | 207 |
| Lau | 207 |
| COVID- | 207 |
| Baricitinib | 207 |
| BALF | 207 |
| EBV | 206 |
| Complex | 206 |
| Microbiol | 206 |
| Nigeria | 205 |
| NAbs | 205 |
| Madrid | 205 |
| Genomics | 205 |
| DG | 205 |
| ChAdOx1 | 205 |
| Barre | 205 |
| Antigenicity | 205 |
| Peng | 205 |
| ORF10 | 204 |
| Hu-1 | 204 |
| Martin | 204 |
| RTC | 204 |
| Service | 204 |
| Workers | 204 |
| herpes | 204 |
| multiorgan | 204 |
| Tables | 203 |
| TBK1 | 203 |
| Su | 203 |
| HeLa | 203 |
| GGO | 203 |
| ECG | 203 |
| PJP | 202 |
| EU | 202 |
| James | 202 |
| PA | 202 |
| LV | 202 |
| Triton | 202 |
| p.i | 202 |
| une | 202 |
| esta | 202 |
| Total | 201 |
| ICUs | 201 |
| Helsinki | 201 |
| Euroimmun | 201 |
| Eq | 201 |
| Engineering | 201 |
| DiaSorin | 201 |
| Koch | 200 |
| GST | 200 |
| Akt | 200 |
| Population | 200 |
| Robert | 200 |
| Renin | 200 |
| transmembrane | 199 |
| Student | 199 |
| Recognition | 199 |
| Quality | 199 |
| Index | 199 |
| Inactivation | 199 |
| IgG. | 198 |
| Ang-(1 | 198 |
| Bangladesh | 198 |
| betacoronavirus | 198 |
| Immunogenicity | 198 |
| Jun | 198 |
| Randomized | 198 |
| ROC | 197 |
| Consensus | 197 |
| Allergy | 197 |
| Southern | 197 |
| dem | 197 |
| nsp14 | 196 |
| neurotropic | 196 |
| Chimera | 196 |
| CLQ | 196 |
| Abs | 196 |
| NIC | 195 |
| DM | 195 |
| Day | 195 |
| LLC | 195 |
| Mas | 195 |
| E2 | 195 |
| Nsp15 | 195 |
| PL | 195 |
| debe | 195 |
| Xia | 195 |
| coronavirus-2 | 195 |
| PJ | 195 |
| HPA | 194 |
| Age | 194 |
| Autophagy | 194 |
| Cohort | 194 |
| Daniel | 194 |
| TF | 194 |
| Ser | 194 |
| einem | 194 |
| síntomas | 194 |
| trimeric | 194 |
| PIMS | 193 |
| CK | 193 |
| IgG1 | 193 |
| polyprotein | 193 |
| Urbani | 193 |
| nM | 193 |
| Wilcoxon | 193 |
| UTR | 192 |
| Therapeutics | 192 |
| Gilead | 192 |
| Factor | 192 |
| Dysregulation | 192 |
| Pro | 191 |
| Personal | 191 |
| Herpes | 191 |
| GRP78 | 191 |
| Liang | 190 |
| CS | 190 |
| Genetic | 190 |
| PD-1 | 190 |
| MDA5 | 190 |
| Mexico | 190 |
| trans | 190 |
| HP | 189 |
| HCP | 189 |
| English | 189 |
| EGFP | 189 |
| Cl | 189 |
| Induction | 188 |
| ANOVA | 188 |
| 3b | 188 |
| SYBR | 188 |
| hCoV | 188 |
| VEGF | 188 |
| À1 | 187 |
| manejo | 187 |
| días | 187 |
| apo | 187 |
| Young | 187 |
| Ye | 187 |
| Protective | 187 |
| Mini | 187 |
| GC | 187 |
| Biology | 187 |
| Consortium | 186 |
| Dexamethasone | 186 |
| Infected | 186 |
| Xpress | 186 |
| mayor | 186 |
| Trials | 186 |
| mouse | 185 |
| Transcription | 185 |
| RdRP | 185 |
| Peter | 185 |
| Miller | 185 |
| MBL | 185 |
| Gln | 185 |
| Chicago | 185 |
| CHO | 185 |
| Immunol | 184 |
| CH | 184 |
| Cases | 184 |
| MA15 | 184 |
| lymphocytopenia | 184 |
| T2 | 184 |
| china | 183 |
| Transplant | 183 |
| SASA | 183 |
| Hendra | 183 |
| Vaccines | 182 |
| TS | 182 |
| Russia | 182 |
| Practice | 182 |
| Organ | 182 |
| Evolution | 182 |
| Chai | 182 |
| CKD | 182 |
| Special | 182 |
| M(pro | 181 |
| Grant | 181 |
| POC | 181 |
| Map | 181 |
| Parkinson | 181 |
| Seattle | 180 |
| Res | 180 |
| MS2 | 180 |
| Lymphopenia | 180 |
| HLH | 180 |
| Gly | 180 |
| Cov2 | 180 |
| Background | 180 |
| Proteins | 179 |
| FCS | 179 |
| Feng | 179 |
| Lai | 179 |
| Library | 179 |
| darunavir | 179 |
| Real | 179 |
| TNFα | 179 |
| ventilación | 179 |
| S7 | 179 |
| Joint | 178 |
| Da | 178 |
| IL-7 | 178 |
| Initiative | 178 |
| African | 178 |
| Main | 178 |
| Poisson | 178 |
| Task | 178 |
| antigen | 178 |
| si | 177 |
| analysis | 177 |
| UVGI | 177 |
| Responses | 177 |
| Dependent | 177 |
| Chain | 177 |
| Fang | 176 |
| -80 | 176 |
| 2c | 176 |
| Cardiology | 176 |
| Cox | 176 |
| Carlo | 176 |
| HSV | 176 |
| organoids | 176 |
| SAS | 176 |
| SNPs | 176 |
| key | 176 |
| Leung | 176 |
| corona | 175 |
| LRT | 175 |
| IEDB | 175 |
| DE | 175 |
| Overview | 174 |
| HFNC | 174 |
| En | 174 |
| Spread | 174 |
| Target | 174 |
| PAI-1 | 173 |
| O | 173 |
| Modeling | 173 |
| H3N2 | 173 |
| Epitope | 173 |
| Denmark | 173 |
| DS | 173 |
| Cluster | 173 |
| ClinicalTrials.gov | 173 |
| 2b | 173 |
| BC | 172 |
| Hui | 172 |
| Emergence | 172 |
| Figs | 172 |
| Ca | 172 |
| IPC | 172 |
| Treg | 172 |
| Zealand | 172 |
| ddPCR | 172 |
| Statement | 172 |
| NCP | 171 |
| Crohn | 171 |
| IFR | 171 |
| Interactions | 171 |
| Khan | 171 |
| Congo | 171 |
| NS | 171 |
| Suppl | 171 |
| Susceptibility | 171 |
| este | 171 |
| mortalidad | 171 |
| PM | 171 |
| ORF3b | 170 |
| A1 | 170 |
| MT | 170 |
| DMV | 170 |
| Recombinant | 170 |
| Shen | 170 |
| chez | 170 |
| oseltamivir | 169 |
| Yao | 169 |
| Tissue | 169 |
| Mental | 169 |
| Immunization | 169 |
| Di | 169 |
| Kidney | 168 |
| Characterization | 168 |
| Humoral | 168 |
| Wen | 168 |
| Pathogen | 168 |
| TaqMan | 168 |
| methylprednisolone | 167 |
| Walls | 167 |
| King | 167 |
| Assays | 167 |
| Professor | 166 |
| Ala | 166 |
| IRB | 166 |
| PRV | 166 |
| Extracellular | 166 |
| Scale | 166 |
| UC | 166 |
| Ub | 166 |
| metapneumovirus | 166 |
| https | 165 |
| antibody | 165 |
| Xue | 165 |
| Women | 165 |
| Phylogenetic | 165 |
| PEG | 165 |
| Johns | 165 |
| Ex | 165 |
| ORF7a | 164 |
| Fan | 164 |
| HD | 164 |
| Materials | 164 |
| Mark | 164 |
| Ramachandran | 164 |
| Targets | 164 |
| control | 164 |
| à | 164 |
| Guideline | 163 |
| Advisory | 163 |
| Authority | 163 |
| Basis | 163 |
| CTSL | 163 |
| Dipeptidyl | 163 |
| HRCT | 163 |
| PBMC | 163 |
| RR | 163 |
| Zhong | 163 |
| hACE2 | 163 |
| Release | 162 |
| Avian | 162 |
| EK1 | 162 |
| Family | 162 |
| O. | 162 |
| airways | 162 |
| Series | 162 |
| Thrombosis | 162 |
| hasta | 162 |
| serologic | 162 |
| kann | 161 |
| Version | 161 |
| Performance | 161 |
| Luo | 161 |
| Furin | 161 |
| Publisher | 160 |
| ERK | 160 |
| GROMACS | 160 |
| Kenya | 160 |
| Mice | 160 |
| virus | 160 |
| T7 | 160 |
| Wales | 160 |
| kB | 160 |
| nafamostat | 160 |
| UCI | 160 |
| SEM | 159 |
| EV | 159 |
| FFR | 159 |
| Facility | 159 |
| Post | 159 |
| SC | 159 |
| Trust | 159 |
| Zn | 159 |
| health | 159 |
| nAbs | 159 |
| nach | 159 |
| ward | 159 |
| Louis | 158 |
| Airway | 158 |
| Berlin | 158 |
| Class | 158 |
| Das | 158 |
| Du | 158 |
| Janus | 158 |
| baricitinib | 158 |
| QT | 158 |
| Seq | 158 |
| Step | 158 |
| ϭ | 158 |
| kJ | 158 |
| ribavirin | 158 |
| Rev | 158 |
| Master | 157 |
| Amoy | 157 |
| CD14 | 157 |
| NLR | 157 |
| N3 | 157 |
| Pathway | 157 |
| Qi | 157 |
| Pacific | 156 |
| Latin | 156 |
| Mesenchymal | 156 |
| NAC | 156 |
| Nanopore | 156 |
| immunoassays | 156 |
| Singh | 156 |
| Tween | 156 |
| Western | 156 |
| aptamer | 156 |
| Antigen | 155 |
| C1 | 155 |
| GAPDH | 155 |
| Corman | 155 |
| Functional | 155 |
| Reporting | 155 |
| HL | 155 |
| Infektion | 155 |
| Mortality | 155 |
| clínica | 155 |
| personal | 155 |
| ASC | 154 |
| Atlas | 154 |
| Authorization | 154 |
| Corporation | 154 |
| Cys145 | 154 |
| Editor | 154 |
| Es | 154 |
| IL-6R | 154 |
| Integrated | 154 |
| Sarbecovirus | 154 |
| Sequencing | 154 |
| TCID50 | 154 |
| Ho | 153 |
| Boltzmann | 153 |
| CV | 153 |
| Chu | 153 |
| Environment | 153 |
| Ali | 153 |
| Mass | 153 |
| OH | 153 |
| Presymptomatic | 153 |
| son | 153 |
| Ng | 153 |
| Low | 152 |
| -3 | 152 |
| Eagle | 152 |
| Olfactory | 152 |
| PRF | 152 |
| RGD | 152 |
| Recovery | 152 |
| Therapeutic | 152 |
| Lan | 151 |
| Collection | 151 |
| Cui | 151 |
| IHC | 151 |
| IL6 | 151 |
| pueden | 151 |
| Mix | 151 |
| Pneumocystis | 151 |
| Survival | 151 |
| ZIKV | 151 |
| Gordon | 150 |
| HEPA | 150 |
| Level | 150 |
| Leishmania | 150 |
| Indian | 150 |
| Lys | 150 |
| für | 150 |
| ne | 150 |
| été | 150 |
| Screening | 150 |
| OE | 149 |
| Beckman | 149 |
| Head | 149 |
| JNK | 149 |
| Lei | 149 |
| SLE | 149 |
| Times | 149 |
| alfa | 149 |
| blue | 149 |
| chemoattractant | 149 |
| Klebsiella | 148 |
| AA | 148 |
| Education | 148 |
| Egypt | 148 |
| Excel | 148 |
| HAE | 148 |
| Hiltonol | 148 |
| IVIg | 148 |
| Spanish | 148 |
| LD | 148 |
| Newcastle | 148 |
| Occupational | 148 |
| PR | 148 |
| Sera | 148 |
| Situation | 148 |
| cDNA | 148 |
| Epub | 147 |
| Prof. | 147 |
| Python | 147 |
| Serologic | 147 |
| fue | 147 |
| ebselen | 146 |
| Statistics | 146 |
| SE | 146 |
| Resource | 146 |
| Novaferon | 146 |
| NJ | 146 |
| Las | 146 |
| Incubation | 146 |
| FITC | 146 |
| Austria | 146 |
| Upper | 146 |
| Neurological | 145 |
| CoV-2-RBD | 145 |
| Gupta | 145 |
| HE | 145 |
| LSPR | 145 |
| Texas | 145 |
| PBST | 145 |
| PLP | 145 |
| Pseudomonas | 145 |
| microRNA | 145 |
| einen | 145 |
| Macrophage | 144 |
| Basel | 144 |
| Computing | 144 |
| Dulbecco | 144 |
| Insights | 144 |
| Johnson | 144 |
| Market | 144 |
| Red | 144 |
| día | 144 |
| hyperimmune | 144 |
| RP | 144 |
| Estimation | 143 |
| Anosmia | 143 |
| CE | 143 |
| Cov | 143 |
| FACS | 143 |
| Milan | 143 |
| PPV | 143 |
| Southeast | 143 |
| alta | 143 |
| NPA | 142 |
| Computational | 142 |
| L1 | 142 |
| LFIA | 142 |
| Retrospective | 142 |
| Pregnancy | 142 |
| Probe | 142 |
| Stroke | 142 |
| zum | 141 |
| St. | 141 |
| News | 141 |
| Cq | 141 |
| RANTES | 140 |
| -1 | 140 |
| Deng | 140 |
| Docking | 140 |
| Nguyen | 140 |
| AngII | 140 |
| Reviews | 140 |
| TLRs | 140 |
| medidas | 140 |
| respiratoria | 140 |
| protein-1 | 140 |
| SR | 140 |
| Innate | 139 |
| ECDC | 139 |
| Genetics | 139 |
| Humans | 139 |
| Multiple | 139 |
| NSP6 | 139 |
| Neurologic | 139 |
| Tian | 139 |
| https://doi.org/10.1101 | 139 |
| wie | 139 |
| PRNT | 138 |
| Cai | 138 |
| File | 138 |
| Ltd | 138 |
| Nursing | 138 |
| PET | 138 |
| Coagulopathy | 138 |
| Pre | 138 |
| SNV | 138 |
| data | 138 |
| ␣ | 138 |
| über | 138 |
| Resources | 138 |
| Radiology | 137 |
| GA | 137 |
| Jing | 137 |
| P3 | 137 |
| Strategy | 137 |
| Silva | 137 |
| colistin | 137 |
| fueron | 137 |
| grupo | 137 |
| Carlos | 136 |
| Act | 136 |
| Asian | 136 |
| Asymptomatic | 136 |
| Gardens | 136 |
| Chin | 136 |
| Clinic | 136 |
| Tests | 136 |
| MV | 135 |
| ACS | 135 |
| Biosafety | 135 |
| Ding | 135 |
| FDR | 135 |
| Fab | 135 |
| Jean | 135 |
| Knowledge | 135 |
| Lipinski | 135 |
| ARTIC | 135 |
| NICU | 135 |
| Pediatr | 135 |
| Phe | 135 |
| Renal | 135 |
| Scopus | 135 |
| Self | 135 |
| sarilumab | 135 |
| Zeng | 135 |
| PLA | 135 |
| Injury | 134 |
| Ahmed | 134 |
| Box | 134 |
| Cepheid | 134 |
| Correlation | 134 |
| Equipment | 134 |
| Oncology | 134 |
| Products | 134 |
| QSAR | 134 |
| Quantitative | 134 |
| Registry | 134 |
| SIR | 134 |
| sospecha | 134 |
| MVA | 133 |
| Breakthrough | 133 |
| C57BL/6 | 133 |
| Canadian | 133 |
| Chou | 133 |
| Fast | 133 |
| Fund | 133 |
| ISG | 133 |
| CoV-2-S | 133 |
| Perlman | 133 |
| Royal | 133 |
| SARScoronavirus | 133 |
| Seafood | 133 |
| Thr | 133 |
| UPR | 133 |
| Wan | 133 |
| Welfare | 133 |
| Qin | 133 |
| Profile | 132 |
| BSL-3 | 132 |
| COV2 | 132 |
| Marco | 132 |
| Nasopharyngeal | 132 |
| Preparedness | 132 |
| Complement | 132 |
| Santa | 132 |
| Si | 132 |
| Sinai | 132 |
| Xie | 132 |
| appendix | 132 |
| general | 132 |
| nsp13 | 132 |
| Alexander | 131 |
| HEPES | 131 |
| Nations | 131 |
| Online | 131 |
| Poland | 131 |
| RTV | 131 |
| Rg | 131 |
| Security | 131 |
| pandemic | 131 |
| red | 131 |
| sec | 131 |
| Boston | 130 |
| Cat | 130 |
| Models | 130 |
| Christian | 130 |
| Cohen | 130 |
| IBM | 130 |
| durante | 130 |
| Richard | 130 |
| Ying | 130 |
| evidencia | 130 |
| tiempo | 130 |
| Wrapp | 130 |
| NPs | 129 |
| DVT | 129 |
| Evolutionary | 129 |
| Francisco | 129 |
| Jones | 129 |
| PUI | 129 |
| Sharma | 129 |
| así | 129 |
| human | 129 |
| otros | 129 |
| wurde | 129 |
| Laura | 128 |
| Amplification | 128 |
| British | 128 |
| G1 | 128 |
| par | 128 |
| Regulation | 128 |
| Specimens | 128 |
| Yuen | 128 |
| Ling | 127 |
| Assembly | 127 |
| Covid | 127 |
| Delhi | 127 |
| Delivery | 127 |
| ET | 127 |
| Eur | 127 |
| Jackson | 127 |
| P4 | 127 |
| Oseltamivir | 127 |
| PKR | 127 |
| PS | 127 |
| PubChem | 127 |
| Ren | 127 |
| Temporal | 127 |
| enoxaparin | 127 |
| ° | 127 |
| Jia | 126 |
| Black | 126 |
| Core | 126 |
| Drosten | 126 |
| EEG | 126 |
| Ewald | 126 |
| H3 | 126 |
| ISG15 | 126 |
| Microsoft | 126 |
| MAFFT | 126 |
| Millipore | 126 |
| QIAamp | 126 |
| Serum | 126 |
| TCZ | 126 |
| Val | 126 |
| © | 126 |
| Glu | 125 |
| Arg | 125 |
| Bei | 125 |
| DrugBank | 125 |
| Failure | 125 |
| max | 125 |
| Reference | 125 |
| rhesus | 125 |
| dl | 125 |
| nd | 125 |
| MCP1 | 124 |
| Anderson | 124 |
| Architect | 124 |
| Clustal | 124 |
| ΔG | 124 |
| Doremalen | 124 |
| Dental | 124 |
| Mv | 124 |
| Nextstrain | 124 |
| Pakistan | 124 |
| TOF | 124 |
| committee | 124 |
| cyclophilin | 124 |
| G614 | 124 |
| Key | 123 |
| AF | 123 |
| Bioinformatics | 123 |
| CoVID-19 | 123 |
| Crisis | 123 |
| Division | 123 |
| ISGs | 123 |
| JAMA | 123 |
| PCT | 123 |
| Philippines | 123 |
| TBS | 123 |
| Tokyo | 123 |
| cytomegalovirus | 123 |
| protección | 123 |
| range | 123 |
| Panther | 123 |
| Observational | 122 |
| BCoV | 122 |
| ENT | 122 |
| NAAT | 122 |
| Method | 122 |
| Regulations | 122 |
| Z. | 122 |
| muestras | 122 |
| sofosbuvir | 122 |
| p<0.0001 | 121 |
| Preliminary | 121 |
| Platform | 121 |
| NIAID | 121 |
| Graham | 121 |
| Epidemiologic | 121 |
| ESR | 121 |
| Anna | 121 |
| GC376 | 120 |
| AAT | 120 |
| BMJ | 120 |
| Cobas | 120 |
| French | 120 |
| Ming | 120 |
| Murine | 120 |
| ORF9b | 120 |
| Thoracic | 120 |
| mL. | 120 |
| Positive | 119 |
| AT | 119 |
| GmbH | 119 |
| ERGIC | 119 |
| Sanger | 119 |
| T1 | 119 |
| URT | 119 |
| ebola | 119 |
| Obesity | 118 |
| 3c | 118 |
| Antonio | 118 |
| Corticosteroid | 118 |
| Free | 118 |
| Guide | 118 |
| Indonesia | 118 |
| MEM | 118 |
| Norway | 118 |
| Chongqing | 118 |
| Paulo | 118 |
| Presence | 118 |
| Regional | 118 |
| Spring | 118 |
| Stress | 118 |
| Transplantation | 118 |
| resultados | 118 |
| cis | 118 |
| lung | 118 |
| Plan | 118 |
| CRKP | 117 |
| Gag | 117 |
| EVD | 117 |
| Cas13 | 117 |
| AE | 117 |
| CD19 | 117 |
| BHB | 117 |
| Andrea | 117 |
| Huh7 | 117 |
| Generation | 117 |
| Matrix | 117 |
| MALDI | 117 |
| Monte | 117 |
| Mount | 117 |
| NADPH | 117 |
| Number | 117 |
| Position | 117 |
| T4 | 117 |
| X. | 117 |
| nsp4 | 117 |
| Inc | 116 |
| Andrew | 116 |
| Common | 116 |
| Concern | 116 |
| Eastern | 116 |
| Frankfurt | 116 |
| HCoV-19 | 116 |
| Hill | 116 |
| KEGG | 116 |
| MERS- | 116 |
| NAT | 116 |
| Nanjing | 116 |
| Plasmodium | 116 |
| TRAF3 | 116 |
| pero | 116 |
| CTSB | 115 |
| Joseph | 115 |
| Intracellular | 115 |
| FL | 115 |
| AG | 115 |
| Bayesian | 115 |
| Anakinra | 115 |
| AMCI | 115 |
| Log | 115 |
| Juan | 115 |
| Mao | 115 |
| Mycoplasma | 115 |
| NSAIDs | 115 |
| NYC | 115 |
| Patel | 115 |
| Por | 115 |
| Respir | 115 |
| Support | 115 |
| Tongji | 115 |
| cov-2 | 115 |
| NHP | 115 |
| Loop | 114 |
| HADDOCK | 114 |
| Kaplan | 114 |
| Ventilation | 114 |
| Genes | 114 |
| Matthew | 114 |
| MEPVC | 114 |
| realizar | 114 |
| NSC | 114 |
| Production | 114 |
| SDRA | 114 |
| Tmprss2 | 114 |
| nsp9 | 114 |
| Nrf2 | 114 |
| Intelligence | 113 |
| Advanced | 113 |
| Comprehensive | 113 |
| Encephalitis | 113 |
| FFP2 | 113 |
| FIPV | 113 |
| QTc | 113 |
| NTA | 113 |
| Precautions | 113 |
| WBE | 113 |
| kinetics | 113 |
| tipo | 113 |
| ␥ | 113 |
| GEO | 112 |
| Heparin | 112 |
| RRT | 112 |
| Christopher | 112 |
| CG | 112 |
| RDRP | 112 |
| Isothermal | 112 |
| Simulation | 112 |
| Spectrum | 112 |
| TP | 112 |
| nur | 112 |
| thrombi | 112 |
| vor | 112 |
| Literature | 111 |
| Abcam | 111 |
| Accession | 111 |
| Adult | 111 |
| Asp | 111 |
| Basic | 111 |
| C2 | 111 |
| CLL | 111 |
| Chlamydia | 111 |
| Jose | 111 |
| HPLC | 111 |
| Massachusetts | 111 |
| dosis | 111 |
| recomendaciones | 111 |
| PyMOL | 111 |
| nivel | 111 |
| keine | 111 |
| pp | 111 |
| Strategies | 111 |
| Sino | 111 |
| SCV | 111 |
| Reagent | 111 |
| Monitoring | 110 |
| ABI | 110 |
| Alphacoronavirus | 110 |
| Angeles | 110 |
| DRB1 | 110 |
| German | 110 |
| Hotel | 110 |
| Hung | 110 |
| Inflammasome | 110 |
| Merck | 110 |
| di | 110 |
| PAPR | 110 |
| Water | 110 |
| PHE | 110 |
| coV-2 | 110 |
| Year | 110 |
| h. | 110 |
| Shang | 110 |
| S8 | 110 |
| Period | 110 |
| Section | 109 |
| Agents | 109 |
| Agilent | 109 |
| Chemistry | 109 |
| Classification | 109 |
| D614 | 109 |
| Hologic | 109 |
| Law | 109 |
| Meier | 109 |
| Multiplex | 109 |
| LA | 109 |
| Sequence | 109 |
| d'une | 109 |
| TLR2 | 109 |
| pulmonar | 109 |
| mmol | 109 |
| dos | 109 |
| hs | 109 |
| alphacoronavirus | 109 |
| sont | 109 |
| William | 109 |
| TX | 109 |
| Pharmacologic | 108 |
| 293T | 108 |
| Antimicrobial | 108 |
| Combination | 108 |
| PTC299 | 108 |
| Pathogens | 108 |
| TA | 108 |
| Practices | 108 |
| White | 108 |
| clínico | 108 |
| group | 108 |
| µL | 108 |
| FFP3 | 107 |
| ADME | 107 |
| ADT | 107 |
| Biomedical | 107 |
| Buffer | 107 |
| CCL5 | 107 |
| ECD | 107 |
| Child | 107 |
| FIP | 107 |
| Huh-7 | 107 |
| Luminex | 107 |
| ORF7b | 107 |
| Ping | 107 |
| UniProt | 107 |
| metformin | 107 |
| Future | 107 |
| Initial | 106 |
| Cytokines | 106 |
| Economic | 106 |
| Elecsys | 106 |
| GMP | 106 |
| HTL | 106 |
| ICTV | 106 |
| Induced | 106 |
| Iceland | 106 |
| Min | 106 |
| ORF8b | 106 |
| STAT | 106 |
| Signaling | 106 |
| Supp | 106 |
| pneumocyte | 106 |
| ≈ | 106 |
| NSP3 | 106 |
| CEA | 105 |
| HRV | 105 |
| HKU4 | 105 |
| DAPI | 105 |
| Coulter | 105 |
| AT1 | 105 |
| CD16 | 105 |
| BST2 | 105 |
| Asthma | 105 |
| Involvement | 105 |
| HTLV | 105 |
| Rhesus | 105 |
| Ji | 105 |
| Transmembrane | 105 |
| MEDLINE | 105 |
| est | 105 |
| caspase-1 | 105 |
| sein | 105 |
| tein | 105 |
| Neck | 105 |
| NaCl | 105 |
| MR | 105 |
| Persistence | 104 |
| Atlanta | 104 |
| Culture | 104 |
| Current | 104 |
| ELISPOT | 104 |
| Exposure | 104 |
| Field | 104 |
| HF | 104 |
| NC_045512.2 | 104 |
| Short | 104 |
| wuhan | 104 |
| UV | 104 |
| Vascular | 104 |
| War | 104 |
| Wilson | 104 |
| jedoch | 104 |
| mecánica | 104 |
| Text | 104 |
| DNase-1 | 103 |
| Francesco | 103 |
| Forum | 103 |
| ENaC | 103 |
| Manifestations | 103 |
| Collaborative | 103 |
| Acid | 103 |
| -2 | 103 |
| Ligand | 103 |
| b. | 103 |
| Monoclonal | 103 |
| OA | 103 |
| Recombination | 103 |
| SCoV | 103 |
| Therapie | 103 |
| Zou | 103 |
| arbidol | 103 |
| Monocyte | 103 |
| Houston | 102 |
| Mucosal | 102 |
| Major | 102 |
| Hua | 102 |
| ATPase | 102 |
| Greece | 102 |
| Fu | 102 |
| Eine | 102 |
| Prevalence | 102 |
| Paolo | 102 |
| BSL3 | 102 |
| Proteomics | 102 |
| Serological | 102 |
| Tools | 102 |
| U. | 102 |
| Wallis | 102 |
| administration | 102 |
| angiotensin | 102 |
| respiratorio | 102 |
| baicalin | 102 |
| SAM | 102 |
| Corticosteroids | 101 |
| LH | 101 |
| Finland | 101 |
| Ethical | 101 |
| Electron | 101 |
| AB | 101 |
| CRRT | 101 |
| CD68 | 101 |
| Adenovirus | 101 |
| APC | 101 |
| Pasteur | 101 |
| MRSA | 101 |
| PI3K | 101 |
| https:// | 101 |
| Rota | 101 |
| Traditional | 101 |
| Un | 101 |
| Units | 101 |
| bis | 101 |
| cm | 101 |
| disulfiram | 101 |
| losartan | 101 |
| methotrexate | 101 |
| Prime | 101 |
|  | 101 |
| Lipid | 100 |
| Lim | 100 |
| NEB | 100 |
| MG | 100 |
| Illness | 100 |
| Jian | 100 |
| ASX | 100 |
| Hz | 100 |
| Defense | 100 |
| CHARMM | 100 |
| Au | 100 |
| Marra | 100 |
| rd | 100 |
| Qiu | 100 |
| TSS | 100 |
| Quarantine | 100 |
| sowie | 100 |
| ni | 100 |
| acid | 100 |
| lactoferrin | 100 |
| TFF2 | 100 |
| Scholar | 100 |
| Sarah | 100 |
| Sample | 100 |
| Gautret | 99 |
| Met | 99 |
| JAK2 | 99 |
| Interventions | 99 |
| Immunoglobulin | 99 |
| Ge | 99 |
| Blockers | 99 |
| Dimer | 99 |
| Critically | 99 |
| Chung | 99 |
| Brown | 99 |
| Multicenter | 99 |
| ASP-1 | 99 |
| Multi | 99 |
| número | 99 |
| NAD | 99 |
| Yong | 99 |
| Pediatrics | 99 |
| unter | 99 |
| niveles | 99 |
| ingreso | 99 |
| datos | 99 |
| tagged | 99 |
| Unique | 99 |
| Umifenovir | 99 |
| Surgery | 99 |
| Seoul | 99 |
| Prince | 99 |
| SIV | 98 |
| ACHD | 98 |
| AMPK | 98 |
| Blue | 98 |
| Guinea | 98 |
| Hospitals | 98 |
| Mission | 98 |
| NSP15 | 98 |
| RNAi | 98 |
| Resistance | 98 |
| SVM | 98 |
| Studio | 98 |
| Tregs | 98 |
| años | 98 |
| cuidados | 98 |
| https://doi.org/10 | 98 |
| können | 98 |
| momento | 98 |
| Santos | 98 |
| todos | 98 |
| Primary | 97 |
| G2 | 97 |
| Jie | 97 |
| Institut | 97 |
| George | 97 |
| GTP | 97 |
| Asn | 97 |
| Epitopes | 97 |
| Brescia | 97 |
| BNP | 97 |
| AES | 97 |
| Nelfinavir | 97 |
| ESC | 97 |
| Pycnogenol | 97 |
| Swiss | 97 |
| R&D | 97 |
| noch | 97 |
| fi | 97 |
| TMA | 97 |
| beta-1b | 97 |
| Studien | 97 |
| Sheahan | 97 |
| SRAS | 97 |
| S100A8 | 97 |
| RCTs | 97 |
| DNase | 96 |
| Hypertension | 96 |
| Hilden | 96 |
| HC | 96 |
| Gold | 96 |
| Direct | 96 |
| APS | 96 |
| Company | 96 |
| COI | 96 |
| Amersham | 96 |
| Airborne | 96 |
| Affiliated | 96 |
| MFI | 96 |
| A549 | 96 |
| LFA | 96 |
| Illinois | 96 |
| Mainland | 96 |
| VERSO | 96 |
| Nucleic | 96 |
| review | 96 |
| pg | 96 |
| menos | 96 |
| http:// | 96 |
| Zhonghua | 96 |
| hepcidin | 96 |
| Trends | 96 |
| SG | 96 |
| Rome | 96 |
| River | 96 |
| RNAdependent | 96 |
| RCSB | 96 |
| Omega | 96 |
| Kinetics | 95 |
| Mutations | 95 |
| Mol | 95 |
| Menachery | 95 |
| Medium | 95 |
| Markov | 95 |
| MO | 95 |
| PP | 95 |
| Experimental | 95 |
| EN | 95 |
| Der | 95 |
| Charles | 95 |
| Biol | 95 |
| Ann | 95 |
| Action | 95 |
| PEI | 95 |
| Square | 95 |
| PSA | 95 |
| a1111111111 | 95 |
| Particle | 95 |
| s. | 95 |
| lymphohistiocytosis | 95 |
| heptad | 95 |
| e. | 95 |
| alto | 95 |
| exosomes | 95 |
| Willebrand | 95 |
| Transcriptomic | 95 |
| Thrombocytopenia | 95 |
| Taipei | 95 |
| salud | 95 |
| Policy | 95 |
| Chem | 94 |
| MgCl | 94 |
| Kruskal | 94 |
| HKU | 94 |
| Fever | 94 |
| Environ | 94 |
| Energy | 94 |
| DAA | 94 |
| Ac | 94 |
| Calmette | 94 |
| Bureau | 94 |
| Artificial | 94 |
| Ana | 94 |
| Alexa | 94 |
| Achilles | 94 |
| Neonatal | 94 |
| NSP8 | 94 |
| Nervous | 94 |
| plasmacytoid | 94 |
| Zinc | 94 |
| también | 94 |
| STAR | 94 |
| owner(s | 94 |
| nsp15 | 94 |
| hypogeusia | 94 |
| desde | 94 |
| ces | 94 |
| famotidine | 94 |
| Waltham | 94 |
| WA | 94 |
| Veterinary | 94 |
| Verlauf | 94 |
| TRT | 94 |
| Simplexa | 94 |
| Sharing | 94 |
| Digital | 93 |
| Medline | 93 |
| Legionella | 93 |
| Korean | 93 |
| Hg | 93 |
| GS-441524 | 93 |
| GP | 93 |
| OB | 93 |
| Cytomegalovirus | 93 |
| Baric | 93 |
| Autodock | 93 |
| Alignment | 93 |
| ACE1 | 93 |
| A1AT | 93 |
| Myocardial | 93 |
| UTP | 93 |
| PICU | 93 |
| diferentes | 93 |
| Qatar | 93 |
| proprotein | 93 |
| poly | 93 |
| nsp2 | 93 |
| non | 93 |
| il | 93 |
| nsp12 | 93 |